Small Molecules

Patient needs are changing, but small molecule drugs remain as important as ever. Here are some tips for development success.

Could J&J’s combination treatment for PAH bridge the gaps between guidelines and practice, while easing the burden on patients?

Following on from deaths attributed to contaminated medicines, here’s how the US Pharmacopeia is promoting testing for DEG and EG.

Biological engineering project featuring GSK seeks to use food by-products to create antimicrobials.

We ask about the story behind Nanoform and what nanotechnology could do for drug formulation.

Acknowledging the monumental successes of the measles vaccine developer and “true giant” of science, medicine, and public health

Why the FDA must delete its statement that people are not horses (or cows), referring to ivermectin use

Lipid nanoparticles are a cornerstone of mRNA therapeutics. For manufacturing, will you choose stainless steel or single-use?

It’s already used for processing powders in many industries, but here’s why pastillation should come to pharma next.

Sitting Down With Christian Baber of the Pistoia Alliance